1. Home
  2. BWAY vs EOLS Comparison

BWAY vs EOLS Comparison

Compare BWAY & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.89

Market Cap

578.5M

Sector

Health Care

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$8.31

Market Cap

550.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWAY
EOLS
Founded
2003
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.5M
550.9M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
BWAY
EOLS
Price
$16.89
$8.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$13.25
$15.50
AVG Volume (30 Days)
157.5K
949.9K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$309.69
$13.27
Revenue Next Year
$26.21
$17.62
P/E Ratio
$81.98
N/A
Revenue Growth
N/A
11.61
52 Week Low
$11.77
$3.86
52 Week High
$26.63
$8.43

Technical Indicators

Market Signals
Indicator
BWAY
EOLS
Relative Strength Index (RSI) 60.51 74.84
Support Level $14.13 $6.44
Resistance Level $18.05 N/A
Average True Range (ATR) 0.90 0.39
MACD 0.09 0.27
Stochastic Oscillator 84.05 95.13

Price Performance

Historical Comparison
BWAY
EOLS

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: